DOI:
10.1039/B104021A
(Communication)
Chem. Commun., 2001, 1396-1397
[Ru(η6-p-cymene)Cl2
(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo- [3.3.1.1]decane): a
water soluble compound that exhibits pH dependent DNA binding providing
selectivity for diseased cells
Received (in Cambridge, UK) 4th May 2001, Accepted 20th June 2001
First published on 11th July 2001
Abstract
The water soluble complex
[Ru(η6-p-cymene)Cl2(pta)] (pta =
1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane), exhibits pH dependent DNA
damage; the pH at which damage is greatest correlates well to the pH
environment of cancer cells.
Current inorganic drugs such as cisplatin are successfully used
in the treatment of many cancers, including testicular, ovarian,
oropharyngeal, bronchogenic, cervical and bladder carcinomas, lymphoma,
osteosarcoma, melanoma and neuroblastoma.1
However there are problems associated with their use including general
toxicity (leading to side effects) and drug resistance. The general
toxicity of cisplatin has been reduced by the development of special
drug-dosing protocols,2 but the need for
further improvements remains. In contrast, the ruthenium based anticancer
drug, recently launched in the clinic
ImH[trans-RuCl4(DMSO)Im] (NAMI-A), shows a remarkably
low general toxicity.3 Since ruthenium
complexes have been shown to specifically accumulate in tumour
cells,4 the reduced general toxicity of
NAMI-A compared to platinum drugs could be due to ruthenium selectivity. In
this paper we describe a new ruthenium compound that exhibits pH dependent
DNA damage, which could show increased selectivity towards cancer cells and
reduce toxic side effects in healthy cells.The reaction of
[Ru(η6-p-cymene)Cl2]2 with
two equivalents of 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane,
pta,5 under reflux in methanol, for 24 h
affords [Ru(η6-p-cymene)Cl2(pta)] 1
in high yield.6 Characterisation of
1 was achieved using mass spectrometry and NMR spectroscopy.7
The molecular structure of 1 (Fig.
1) has been determined by single crystal X-ray diffraction 8 and contains two independent molecules in the
asymmetric unit. The C6-ring is coordinated to the
ruthenium(II) centre with an average Ru–C bond length of
2.20 and 2.21 Å in each molecule. Two chlorine ligands (mean
Ru–Cl 2.42 Å and 2.43 Å in each molecule) and the pta
group [Ru–P 2.296(2) and 2.298(3) Å in each molecule] make up
the rest of the coordination sphere. All parameters are in keeping with
previously determined structures related to 1, which vary in the
nature of the arene and phosphine ligands.9
|
| Fig. 1 The molecular structure of one of the independent molecules of
1. | |
The presence of the pta ligand provides 1 with versatile
soluble properties. For example, 1 and 1 + H+
are soluble in water and polar organic solvents such as CHCl3,
CH2Cl2 and (CH3)2CO.
Protonation of the pta ligand influences the solubility properties, with
the deprotonated species having a higher solubility in organic solvents.
The pKa of 1 was estimated as 6.5 by
monitoring the change in absorbance at 455 nm. We recognised that the pH
dependant solubility of phosphaamine ligands like pta could also be
exploited in biological systems, with the possibility of providing clinical
uses. At physiological pH the predominant species carries no charge and
hence can diffuse through lipid membranes and move freely into and within
cells. In some diseased tissues the pH is reduced due to the associated
changes in metabolism and in this environment the pta ligand is protonated,
trapping 1 in the cell. In addition, we have shown that the
protonated species induces DNA damage more readily than unprotonated 1
(see below).
The DNA substrate used in agarose gel electrophoresis10 is 95% supercoiled (SC) and 5% open circular
(OC), and their positions can be distinguished on the gel (Fig. 2). The results show that when DNA is incubated
with 1 at pH 7.5 or above, the DNA migrates similarly to the DNA
substrate. These results are in accordance with independent studies using a
ruthenium(II)–arene compound, with a DMSO ligand in place
of the pta in 1, that did not detect an interaction with
DNA.11 However, at pH 7.0, the SC form of
DNA incubated with 1 is slightly retarded compared to the
substrate DNA and the retardation is progressively increased as the pH is
reduced. At all pH values the position of OC DNA in the gel remains the
same, indicating that the pH dependent retardation of SC DNA by 1
is not due to charge neutralisation.
|
| Fig. 2 Comparison of DNA damage induced by 1 incubated at different pH
values; visualised by electrophoretic DNA migration in an agarose gel. | |
The pH range over which 1 retards DNA migration closely matches
the pKa of the pta ligand, and as DNA is negatively
charged, it would be expected that the interaction between these two
species would be promoted if they each carried opposite charges. The
importance of this result is that DNA binding is not favoured at
physiological pH. Many diseased cells have a reduced pH, due to metabolic
changes in part associated with the accelerated cell division.12 Thus, 1 would have a higher affinity
for DNA in diseased cells, compared to healthy cells, providing a means of
selectivity.
Further studies are currently in progress to delineate the way in which
1 with interacts with DNA. We are also comparing the effect that
the type of arene ligand has on DNA and the results obtained from these
studies will be reported in due course.
Acknowledgements
We would like to thank to thank The Royal Society for a University
Research Fellowship (P. J. D. and S. L. H.) and The University of York for
financial support (D. J. E).Notes and references
- J. Reedijk, Chem. Commun., 1996, 801 RSC; E. Wong and
C. M. Giandomenico,
Chem. Rev., 1999, 99,
2451 and references therein. Search PubMed.
- J. Reedijk,
Chem. Rev., 1999, 99,
2499 and references therein. Search PubMed.
- R. Gagliardi, G. Sava, S. Pacor, G. Mestroni and E. Alessio, Clin. Exp. Metastasis., 1994, 12, 93 CAS.
- S. C. Srivastava,
P. Richard,
G. E. Meinken,
S. M. Larson and
Z. Grunbaum, in
Radiopharmaceuticals–Structure–Activity
relationships, ed. R. P. Spencer, Grune & Stratton
Inc., New York, 1981,
pp. 207–223. Search PubMed.
- Synthesis of pta: D. J. Daigle, A. B. Pepperman and S. L. Vail, J. Heterocycl. Chem., 1974, 17, 407 Search PubMed.
- Synthesis of
Ru(η6-p-cymene)Cl2(pta) 1: a
methanolic solution of
[Ru(η6-p-cymene)Cl2]2 (200
mg, 0.33 mmol) and pta (1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane), 103
mg, 0.66 mmol) was refluxed for 24 h. The solution was allowed to cool to
room temperature and filtered. Removal of the solvent affords a red
microcrystalline product
Ru(η6-p-cymene)Cl2(pta) 1 (281
mg, 92%)..
- Spectroscopic data for 1: Positive ion
electrospray mass spectrum (H2O): 486 (rel. int. 13)
[Ru(η6-p-cymene)Cl2(pta) +
Na]+ (calc. 486.358), 464 (rel. int. 4)
[Ru(η6-p-cymene)Cl2(pta) + H]+
(calc. 464.376), 428 (rel. int. 100)
[Ru(η6-p-cymene)Cl(pta)]+ (calc.
427.918). 31P NMR (CDCl3) δ
−36.63 (s). 1H NMR (CDCl3) δ
5.46 (q, J 19.73 Hz, 4 p-cymeme), 4.53 (s, 6
NCH2N), 4.32 (s, 6 PCH2N), 2.78 (septet, J
41.37 Hz, CH), 2.08 (s, 3 CH3), 1.22 (d, J 6.93
Hz, 6 CH3). Anal. Found: (calc.) C, 41.14 (41.47); H, 5.66
(5.66)%..
- Structural details of 1: single crystals of
1·CH2Cl2 suitable for crystallography
were grown from a dichloromethane–hexane solution at 4 °C. Data
were collected on a Bruker SMART-CCD equipped with an Oxford Cryostreams
low temperature device. Crystal data for 1:
[RuCl2(PC6H12N3)(C10
H14)]·CH2Cl2, red needle of
dimensions 0.38 × 0.12 × 0.10, M = 548.26,
orthorhombic, space group Pna21, Z = 8, a =
13.2180 (11), b = 15.8201(13), c = 20.8468(18),
U = 4354.3(6) Å3, Dc = 1.673 g
cm−3, T = 150(2) K, F(000) = 2224,
Mo-Kα radiation (λ = 0.71073 ), μ = 1.292
mm−1, reflections measured in the range 1.62 ≤
θ
≤ 23.32°, 5356 unique (Rint =
0.0744). The structure was solved by direct methods and refined by
full-matrix least squares on F2 [SHELXTL NT (G. M.
Sheldrick, SHELXL97, an integrated system for solving and refining crystal
structures from diffraction data, University of Göttingen, Germany,
1997)] to R1 = 0.0476, wR2 = 0.1255, S = 1.060,
for 4825 reflections with F > 4σ(F) and
476 refined parameters with allowance for the thermal anisotropy of all
non-hydrogen atoms. A semi-empirical absorption correction was applied
based on symmetry equivalent and repeated reflections (minimum and maximum
transmission coefficients 0.657 and 0.928). Minimum and maximum final
electron density −1.089 and 1.607 e Å−3. The
largest residual electron density peak 1.61 e− lies close
to a dichloromethane of crystallisation and no sensible crystallographic or
chemical model for this peak could be found. CCDC reference number 161466.
See http://www.rsc.org/suppdata/cc/b1/b104021a/ for
crystallographic data in CIF or other electronic format..
- E. A. V. Ebsworh, R. O. Gould, R. A. Mayo and M. Walkinshaw, J. Chem. Soc., Dalton Trans., 1987, 2831 RSC; W. Keim, P. Kraneburg, G. Dahmen, G. Deckers, U. Englert, K. Linn, T. P. Spaniol, G. Raabe and C. Krüger, Organometallics, 1994, 13, 3085 CrossRef CAS; M. R. J. Elsegood and D. A. Tocher, Polyhedron, 1995, 14, 3147 CrossRef CAS; I. Moldes, E. de la Encarnación, J. Ros, Á. Alvarez-Larena and J. F. Piniella, J. Organomet. Chem., 1998, 566, 165 CrossRef CAS.
- In this assay 2.5 mM 1 in 10 mM phosphate buffer, pH
5.5–8.0 in 0.5 step increments, was incubated for 4 h with 0.05 mg
ml−1 pBR322 DNA. The DNA damage was assessed by comparing
the electrophoretic migration of the species in a 1% agarose gel, prepared
in TAE buffer [40 mM tris(hydroxymethyl)aminomethane acetate and 1 mM EDTA]
with similar migrations of the control incubations: control 1 tested the
activity of 1 under similar assay conditions known to result in
DNA retardation (as above but with no phosphate buffer) and control 2 was
DNA under the same conditions without 1. From each assay, 8 μl
were mixed with 1 μl dye (0.025 mg bromophenol blue, 1 ml glycerol and 1
ml distilled water) and pipetted into wells on the horizontal gel. A
potential difference of 30 mV was applied over the gel for 4 h and the
bands visualised by staining with ethidium bromide. The effect of pH alone
on DNA was assessed by performing a similar experiment in the absence
of 1..
- Y. N. A. Gopal, D. Jayaraju and A. K. Kondapi, Biochemistry, 1999, 38, 4382 CrossRef CAS.
- For example, see: G. R. Martin and R. K. Jain, Cancer Res., 1994, 54, 5670 Search PubMed.
|
This journal is © The Royal Society of Chemistry 2001 |